About AESKU
AESKU is a Healthcare company based in Oakland (United States) founded in 2003 by Torsten Matthias. It offers diagnostic test kits and automation for medical laboratories worldwide. It operates on a B2B model. The company has 2 employees. AESKU has completed 1 acquisition, including DST. Its chief executive is Torsten Matthias. AESKU offers products and services including ELISA Test Kits, IFA Test Kits, Blot Test Kits, and HELIOS System. Its focus areas include Diagnostics, In Vitro Diagnostics, Infectious Serology and Autoimmune Testing. Its legal entity is AESKU, INC. Its competitors include HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Kypha and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
AESKU.GROUP develops and supplies diagnostic solutions including ELISA, IFA, and Blot test kits for autoimmune, infectious serology, and allergy testing. They provide automation systems like HELIOS and HELIA to streamline laboratory processes. Based in Wendelsheim, Germany, with international offices, they serve medical and research institutions through partnerships and distribution agreements. Their products focus on quality control and point-of-care testing to ensure reliable results.
- Employee Count2
- Investments & Acquisitions
Products & Services of AESKU
AESKU offers a comprehensive portfolio of products and services, including ELISA Test Kits, IFA Test Kits, Blot Test Kits, and HELIOS System.
Kits for detecting autoimmune markers through enzyme-linked assays
Test systems for immunofluorescence analysis of diseases
Kits for serological testing of infections and allergies
Automated platform for IFA diagnostics in labs
People of AESKU
10 people are tracked at AESKU (5 in leadership, 5 in team); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Torsten Matthias | Founder, CEO | Leadership |
Kenneth Scott | Director Of Technical Support | Leadership |
François Topin | Sr Director Of Global Sales | Leadership |
Nicole Rankin | Director Of Operations UK | Leadership |
José Carlos Santos | Director Of Product Management | Leadership |
Elliot Bennett | Global Application Specialist | Team |
Hesham Elbedewy | Product Manager | Team |
Panagiotis Gitsioudis | Product Manager Elisa (autoimmunity & Infectious Serology) | Team |
Michael Gibson | Field Service Engineer | Team |
Elisabetta Rampazzo | Country Manager | Team |
Complete people profiles for AESKU
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AESKU
AESKU has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DST.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Innovative in-vitro diagnostic solutions are developed by DST. | dst-diagnostic.com | Schwerin, Germany | 2005 | Apr 2017 | •••• |
Complete acquisition details for AESKU
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of AESKU
2 dated milestones of AESKU across 14 years, from founding to its latest funding, stage changes and deals.
- Founded AESKU is founded.
- Acquisition Acquires DST.
Competitors of AESKU
AESKU has 10 listed competitors in our database, 9 of them funded. They include HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Kypha, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hycorbiomedical.com | 1981 | Garden Grove, United States | $99.57M | – | Developer of diagnostic instruments and reagents for autoimmune diseases and allergies | |
| exagen.com | 2002 | Vista, United States | $110.23M | 204 | Diagnostic and monitoring solutions for autoimmune connective diseases are developed. | |
| lophius.com | 2008 | Regensburg, Germany | $23.73M | 28 | T-cell-based diagnostics for infectious and immune diseases are developed. | |
| predictimmune.com | 2017 | Cambridge, United Kingdom | $18.32M | 15 | Tools for diagnosing immune-mediated inflammatory diseases are developed. | |
| kypha.net | 2009 | Saint Louis, United States | $16.76M | – | Diagnostic biomarker tests for inflammation and autoimmune diseases are developed. | |
| immudex.com | 2009 | Copenhagen, Denmark | $16.35M | 42 | Provider of immune monitoring reagents and services for research and clinical use | |
| cellidx.com | 2012 | San Diego, United States | $1.34M | 7 | Immunodiagnostic reagents for immunohistochemistry are manufactured and marketed. | |
| smarthealthdx.com | 1979 | Irvine, United States | $17.29M | – | Precision diagnostics for vascular, metabolic, and oncological diseases are developed. | |
| protagen.com | 1997 | Dortmund, Germany | $19.84M | 20 | Autoantibody biomarkers are utilized for autoimmune disease diagnostics. | |
| sqidiagnostics.com | 1999 | Toronto, Canada | – | – | Multiplexed tests and automated systems for biological testing are developed. |
Detailed competitors of AESKU
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AESKU
The website of AESKU (aesku.com) receives about 3.9K visits a month and ranks #4,637,133 among all websites worldwide, #5,529 in Biotechnology and Pharmaceuticals.
- Monthly visits3.9K
▲ 2.8% vs previous month
- Unique visitors1.6K
per month
- Global rank#4,637,133
among all websites
- Category rank#5,529
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.7
- Average visit9 sec
- DevicesDesktop 32% · Mobile 68%
Top companies in Infectious Diseases
10 companies that operate in the same segment as AESKU (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | 172 | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | 329 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aesku
Complete news archive for AESKU
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AESKU
AESKU was founded in 2003.
AESKU is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Torsten Matthias is the current CEO of AESKU. They have also founded this company.
AESKU has 2 employees.
AESKU.GROUP develops and supplies diagnostic solutions including ELISA, IFA, and Blot test kits for autoimmune, infectious serology, and allergy testing. They provide automation systems like HELIOS and HELIA to streamline laboratory processes. Based in Wendelsheim, Germany, with international offices, they serve medical and research institutions through partnerships and distribution agreements. Their products focus on quality control and point-of-care testing to ensure reliable results.
AESKU's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
AESKU offers ELISA Test Kits, IFA Test Kits, Blot Test Kits, and HELIOS System.
AESKU has made 1 acquisition, including DST.
AESKU operates through Aesku, Inc..